Retrospective, multicentre study of characterized the pharmacokinetics of raltegravir in HIV-infected liver transplant patients.

Trial Profile

Retrospective, multicentre study of characterized the pharmacokinetics of raltegravir in HIV-infected liver transplant patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Feb 2016

At a glance

  • Drugs Raltegravir (Primary)
  • Indications HIV-1 infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 04 Feb 2016 New trial record
    • 10 Jan 2016 Results published in the Journal of Antimicrobial Chemotherapy
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top